Impact of Patient Characteristics on the Outcomes of Patients with Gastrointestinal Cancers Treated with Immune Checkpoint Inhibitors
Gastrointestinal (GI) cancers are a group of malignancies that globally account for a significant portion of cancer incidence and cancer-related death. Survival outcomes for esophageal, gastric, pancreatic, and hepatobiliary cancers remain poor, but new treatment paradigms are emerging with the adve...
| Main Authors: | , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
MDPI AG
2023-01-01
|
| סדרה: | Current Oncology |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1718-7729/30/1/60 |